Clinical Trial Update: Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating contrast-enhanced ultrasound imaging with Sonazoid for peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Sonazoid (perflubutane)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Peripheral Artery Disease | Phase 2 | Status: UNKNOWN